Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$12,371,640
+$460,079 QoQ
Shares Held
48,713
-0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#985
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON INVESTMENT MANAGEMENT, INC. holds $48,347,417 across 11 Drug Manufacturers - General names. JNJ ranks #1 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
48,713 | $12,371,640 | |
| 2 | PFE |
Pfizer Inc
|
469,287 | $11,300,430 | |
| 3 | ABBV |
AbbVie Inc.
|
34,736 | $8,740,967 | |
| 4 | AMGN |
Amgen Inc
|
18,002 | $6,518,884 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,721 | $6,091,644 | |
| 6 | MRK |
Merck & Co., Inc.
|
24,470 | $3,144,395 | |
| 7 | GSK |
GSK plc
|
1,680 | $88,065 | |
| 8 | AZN |
Astrazeneca PLC
|
324 | $61,436 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,371,640 | 48,713 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $11,911,561 | 48,730 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $10,191,252 | 49,245 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $9,095,592 | 49,054 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $7,623,447 | 49,908 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $8,265,963 | 49,843 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,137,286 | 49,352 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $7,793,789 | 48,092 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $6,881,943 | 47,085 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $7,192,266 | 45,466 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $7,047,657 | 44,964 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $6,947,073 | 44,604 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $7,639,244 | 46,153 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $7,165,805 | 46,231 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $7,747,515 | 43,858 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $7,291,246 | 44,633 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $9,326,197 | 52,539 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $9,487,121 | 53,530 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $9,232,818 | 53,971 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $8,675,780 | 53,720 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $8,928,413 | 54,197 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $8,300,496 | 50,505 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $7,703,436 | 48,948 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $7,611,043 | 51,122 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $7,409,091 | 52,685 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $7,145,667 | 54,493 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||